Cancer Biology for Clinical Data Managers

February 16, 2012: 11.00am EST, 17.00 CET, 21.30 IST

1 part webinar
60-minute presentation followed by 30-minute Q&A   

Overview
Almost all oncology clinical trials include biological correlatives as secondary or tertiary objectives. It is not always intuitive how these biological correlatives relate to the oncology clinical trial or how they were originally linked to cancer. This webinar will examine two biological correlatives SRC and RAS. The historical link between cancer and these genes/proteins will be discussed. Biological pathways containing these genes/proteins will be explored. The historical and biological rationale for a common class of chemotherapy will also be discussed. Finally, the classic paper by Hanahan and Weinberg , “The Hallmarks of Cancer”, will be used to try to tie together clinical trial biological correlatives and cancer biology. 

What You’ll Learn
Attendees will be able to:

1.     Explain the relationship between SRC and RAS and cancer biology.

2.     Describe the early links between biology and cancer.

3.     Describe how SRC and RAS fit in biological pathways associated with cancer.

4.     Explain the rationale for one of the first chemotherapies.

5.     Identify the hallmarks of cancer.

 Meet the Presenter

Tim Breen’s educational background is a Ph.D. in Physiology and M.S. Bioinformatics. He has more than fourteen years’ experience in clinical data management and eight years of experience in oncology clinical data management. He is currently the Director of Clinical Research Informatics at the Hoosier Oncology Group. Prior to coming to the Hoosier Oncology Group, he was a Biostatistics Project Coordinator for the Indiana University, Division of Biostatistics. He is a Certified Clinical Data Manager and a Co-Chair of the SCDM Education and Professional Development Committee. 

Who Should Attend
Advanced and experienced CDMs, CRAs and biostatisticians. 

Course Tuition

Individual: $300 members/$350 non-members

Earn CEUs      
Participants are eligible to receive CEUs upon attendance and successful completion of assessment questions.
SCDM is authorized by IACET to offer 0.2 CEUs for this program.